FDA Orange Book · active-ingredient family
Calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate
Calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINER · NDA 017390
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| PLASMA-LYTE M AND DEXTROSE 5% IN PLASTIC CONTAINERRLD | BAXTER HLTHCARE | NDA 017390 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Calcium chloride; dextrose; magnesium chloride; potassium chloride; sodium acetate; sodium chloride; sodium lactate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
